48 results
Page 2 of 3
424B5
46x9s2ijgzi1wjueg mr
15 Apr 20
Prospectus supplement for primary offering
5:19pm
8-K
EX-10.1
gyim 02vos685wr
15 Apr 20
NeuroBo Pharmaceuticals Announces $7.5 Million Registered Direct Offering
5:13pm
8-K
EX-10.3
v07vi12d
30 Dec 19
Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals
9:04pm
424B3
iwwi4fx3jpevfj
6 Nov 19
Prospectus supplement
9:15am
S-4/A
dluu4m3ubbcduqri
10 Oct 19
Registration of securities issued in business combination transactions (amended)
9:35pm
S-4/A
EX-10.35
3loki62j3p
10 Oct 19
Registration of securities issued in business combination transactions (amended)
9:35pm
S-4
EX-10.42
e2r3se
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.37
tuvglj o0ld6l86
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.39
cuvtwyv9inzb5
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.38
kw2dk8ywq7tygp
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
S-4
x2yq70xgru
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
8-K
EX-2.1
vz2guikgrg5 ei2i1
25 Jul 19
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
6:38am
8-K
EX-10.6
jphhlfs8peoshxf2n
25 Jul 19
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
6:38am
425
EX-2.1
a17sb9hoj0i6pjsz1
25 Jul 19
Business combination disclosure
6:36am
425
EX-10.6
8z0nzlhoyureq hq4s9
25 Jul 19
Business combination disclosure
6:36am